보툴리눔독소 주사 Botulinum Toxin Injection
보톡스 주사를 이용한 주름 개선
주요 저널
- Aesthetic plastic surgery 12
- Plastic and reconstructive surgery 12
- Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 10
- Annals of plastic surgery 4
- Aesthetic surgery journal 3
이 분야 핵심 논문
인용·조회·발간연도 종합 점수- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
전체 논문 목록
9,388건 · 최신순- Successful treatment of hand chronic exertional compartment syndrome with reduced-dose botulinum toxin-A: a case report.
-
A 15-Year Computational Twin Modeling Study of Botulinum Toxin A Frequency and Age-Related Facial Aging.
[INTRODUCTION] Facial aging results from intrinsic biologic decline and extrinsic environmental influences, producing progressive changes in skin structure, collagen integrity, and soft-tissue support. Botulinum neurotoxin type A (BoNTA) is…
-
Effects of botulinum toxin type A on sleep quality in patients with awake and sleep bruxism: a prospective study.
The aim was to investigate the effects of botulinum toxin type A (BTX-A) treatment on sleep quality in patients diagnosed with probable sleep bruxism and awake bruxism. A prospective observational study was conducted on 40 female patients. …
-
Redefining the Treatment Landscape in Gastroparesis: A Clinical Review of Gastric Peroral Endoscopic Myotomy Outcomes and Therapeutic Integration.
Gastroparesis is a chronic gastric motility disorder marked by delayed gastric emptying in the absence of mechanical obstruction. For patients with symptoms refractory to medical and dietary therapy, Gastric Peroral Endoscopic Myotomy (G-PO…
-
Comparing DaxibotulinumtoxinA to OnabotulinumtoxinA for Adductor Laryngeal Dystonia: A Pilot Study.
[OBJECTIVES] Botulinum toxin A (BtxA) injection for AdLD is typically performed approxiamately every 3 months. DaxibotulinumtoxinA-lanm (Daxi) is a peptide-formulated neuromodulator with reported longer therapeutic duration. This study comp…
-
Long-Term Outcomes of Botulinum Toxin in the Treatment of Chronic Anal Fissures: A Stepwise Approach to Managing Recurrent and Persistent Cases.
[BACKGROUND] Chronic anal fissures are a painful condition characterized by a tear in the anal mucosa. Botulinum toxin injection is a minimally invasive treatment option, but long-term effectiveness in recurrent or persistent cases remains …
-
β-Sitosterol ameliorates metabolic dysfunction-associated steatohepatitis by targeting the RAC1/mTOR/TFEB axis thus activating lipophagy-lysosomal pathway.
Metabolic dysfunction-associated steatohepatitis (MASH), an inflammatory subtype of metabolic dysfunction-associated fatty liver disease (MAFLD), drives hepatic dysfunction and poses a significant health burden. Lipophagy dysfunction disrup…
-
Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.
[BACKGROUND] The first International Parkinson and Movement Disorder Society Evidence-Based Medicine (MDS-EBM) review for essential tremor (ET) was published in 2019; since then, the modified Grading of Recommendations, Assessment, Developm…
-
Beyond Wrinkles: A Systematic Review and Meta-analysis of Off-Label Aesthetic Uses of Botulinum Neurotoxin.
[BACKGROUND] Many popular botulinum neurotoxin treatments are off-label, yet no review has comprehensively captured their effects. This study provides a systematic review of neurotoxin's off-label aesthetic applications, focusing on muscle …
-
An Evidence-Based Assessment of Adjuvant Therapy in Autologous Fat Transfer: Ranking of the Potential Agents.
[PURPOSE] Autologous fat transfer is widely used in reconstructive and aesthetic surgery; however, its efficacy is often limited by suboptimal fat graft survival. Various pharmacological adjuncts have been proposed to enhance fat graft viab…
-
AI-Enabled Surveillance and Modelling for Counterfeit Botulinum Toxin A: Risk Projection, Patient Safety, and Systemic Reform of Pharmacovigilance.
[BACKGROUND] Counterfeit Botulinum Toxin A (BoNT-A) poses a growing global threat, particularly in aesthetic medicine where regulatory oversight is minimal and underreporting is widespread. Traditional pharmacovigilance systems such as FAER…
-
Short-term analysis of botulinum toxin A for functional popliteal artery entrapment syndrome.
[OBJECTIVE] Functional popliteal artery entrapment syndrome (fPAES) is characterized by exertional leg pain caused by hypertrophic musculature in young adults. If history, examination and imaging suggest fPAES, treatment is surgical includi…
-
Timeliness and Diagnostic Yield of Suspected Botulism Notifications in a Tertiary Medical Center in Taiwan, 2014-2024.
Botulism is a rare but high-consequence foodborne intoxication in which early recognition and prompt reporting are essential for a timely public health response. We conducted a retrospective review of suspected botulism notifications report…
-
Platelet mTOR Is a Regulator of Sterile Immunothrombosis.
[BACKGROUND] Immunothrombosis entails a tight interplay between thrombotic and inflammatory pathways and plays a pathological role in ischemic stroke and venous thrombosis. mTOR (mechanistic target of rapamycin) is a canonical serine/threon…
- Correction: AI-Enabled Surveillance and Modelling for Counterfeit Botulinum Toxin A: Risk Projection, Patient Safety, and Systemic Reform of Pharmacovigilance.
-
Modified Delphi Consensus Guidelines for Pelvic Floor Botulinum Toxin Injection.
[IMPORTANCE] Myofascial pelvic pain (MPP) is an under-treated etiology of pelvic pain, presenting with pelvic floor tender points and/or increased tension. While limited data support off-label use of pelvic floor botulinum toxin (BTA) injec…
-
Relaxing Environment Lowers Anxiety During Chemodenervation: a Randomized Trial.
[IMPORTANCE] Intradetrusor chemodenervation with onabotulinumtoxinA (BOTOX) injections, a common office-based procedure for overactive bladder (OAB), is associated with patient anxiety and discomfort. Aromatherapy and music have been shown …
- Topical imiquimod in the management of botulinum toxin-induced upper eyelid ptosis: A case series.
-
Is Ready-To-Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple-Blinded Clinical Trial.
[BACKGROUND] Most commercially available botulinum toxin A (BoNT-A) formulations are lyophilized or vacuum-dried powders requiring reconstitution. Recently a ready-to-use formulation (RTUaboBoNT-A) has been introduced. Although its efficacy…
-
Neurophysiological assessment of F-, M-waves and cutaneous silent period in patients with caput patterns of cervical dystonia in the waning phase of botulinum toxin therapy.
[AIM OF THE STUDY] Evaluate and compare F‑wave and cutaneous silent period (CSP) parameters in caput‑pattern idiopathic cervical dystonia (CD) in the waning phase of botulinum toxin therapy vs. healthy controls to identify alterations in se…